THE ALT/LAB · Controlled Lab Entry — · —
THE ALT/LAB
research compounds · united states
Research-Use Verification

All products sold on this website are research-grade materials intended exclusively for laboratory research use by qualified professionals and are not approved for human or veterinary use.

These products are not drugs, foods, cosmetics, or dietary supplements, have not been evaluated by the FDA, and are not intended for human or animal use. Any personal, human, animal, or other non-research use is strictly prohibited.

The statements made within this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure or prevent any disease.

I confirm I am twenty-one (21) years of age or older and a qualified researcher or institutional buyer acquiring these materials for in vitro research only.
I understand these products are for research use only, are not for human or veterinary use, have not been evaluated by the FDA, and I will not administer them to any person, including myself.
— Decline & Exit —
est. United States · 2026 File No. AL/2026/ENTRY-001 For research use only
Free 2-Day shipping on US orders $200+
manufactured in the USA Sterile lyophilised ≥99% purity · HPLC verified for research use only · not for human use
THE ALT/LAB UNITED STATES
(0)
Selank 10mg THE ALT/LABSelank 10mgFor Research Use Only
Not For Human ConsumptionCompounded · USA
research compound · for research use only · neuro research

Selank 10mg

$69.00

For Research Use Only. Not for Human or Veterinary Use. Not a drug, food, or supplement; not evaluated by the FDA; not intended for human or animal use.

View COA →

Specification

identity · literature · handling

Heptapeptide.

Identity
Sequence: Thr-Lys-Pro-Arg-Pro-Gly-Pro (TKPRPGP)
CAS: 129954-34-3
Molecular formula: C33H57N11O9
Purity: ≥99% (HPLC)
Form: sterile lyophilised powder
Presentation: 3 mL vial

Research literature
Research on selank investigates the synthetic heptapeptide Thr-Lys-Pro-Arg-Pro-Gly-Pro, an analogue of the immunomodulator tuftsin developed at the Russian Institute of Molecular Genetics. In-vivo work in rats characterises the peptide’s intranasal regulation of BDNF mRNA and protein expression in the hippocampus. Transcriptomic studies further examine selank’s modulation of hippocampal and spleen gene expression following single and chronic administration, with reported changes in plasma-membrane-associated transcripts.

References

  1. Inozemtseva LS et al. (2008). Intranasal administration of the peptide Selank regulates BDNF expression in the rat hippocampus in vivo. Doklady Biological Sciences. PMID 18841804.
  2. Kolomin T et al. (2013). Transcriptome alteration in hippocampus under the treatment of tuftsin analog Selank. Molekuliarnaia Genetika, Mikrobiologiia i Virusologiia. PMID 24450168.

Documentation
Batch Certificate of Analysis (HPLC, third-party) provided for the lot shipped.

Handling (research)
Store lyophilised cold and protected from light. Reconstitute according to the researcher’s own laboratory procedure.

For Research Use Only. Not for Human or Veterinary Use. Not a drug, food, or supplement; not evaluated by the FDA; not intended for human or animal use.